Brevets sur les 10 dernières années

  1. Routier, S. ; Buron, F. ; Rodrigues, N. ; Fourrière-Grandclaude, G. ; Vandier, C. ; Chantome, A. ; Potier-Cartereaux, M. ; Gueguinou, M. ; Marionneau-Lambot, S.
    Ion channel inhibitor compounds for cancer treatment
    2. Patent N° Kind Date Application N° Date
    WO 2018215557 A1 29 Nov. 2018 WO 2018-EP63543 23 May 2018
    FR 3066761 A1 30 Nov. 2018 FR 2017-54564 23 May 2017
    FR 3066761 B1 30 Oct. 2020
    EP 3630759 A1 8 Apr. 2020 EP 2018-726802 23 May 2018
    CA 3064484 A1 29 Nov. 2018 CA 2018-3064484 23 May 2018
    JP 2020520982 T 16 Jul. 2020 JP 2019-565186 23 May 2018

        Priority Application
                      FR 2017-54564 A 23 May 2017
                      WO 2018-EP63543 W 23 May 2018
        ref. chem. Abstract : 2018:2337629

  2. Svetlana, V. E. ; Suzenet, F. ; Routier, S. ; Ben Othman, R. ; Collet, A. ; Ivana, M. ; Delatouche, R. ; Petoud, S.
    Lanthanide complexes comprising derivatives of triethylenetetramine-​N,​N,​N',​N'',​N''',​N'''-​hexaacetic acid
    3. Patent N° Kind Date Application N° Date
    WO 2018130545 A1 19 Jul. 2018 WO 2018-EP50517 10 Jan. 2018
    FR 3061713 A1 13 Jul. 2018 FR 2017-50240 11 Jan. 2017
    FR 3061713 B1 14 Feb. 2020
    EP 3568402 A1 20 Nov. 2019 EP 2018-700279 10 Jan. 2018
    US 20190330242 A1 31 Oct. 2019 US 2019-16477080 10 Jul. 2019
    US 10669288 B2 2 Jun. 2020

        Priority Application
                      FR 2017-50240 A 11 Jan. 2017
                      WO 2018-EP50517 W 10 Jan. 2018
        ref. chem. Abstract : 2018:1336212

  3. Routier, S. ; Suzenet, F. ; Chalon, S. ; Buron, F. ; Vercouillie, J. ; Melki, R. ; Boiaryna, L. ; Guilloteau, D. ; Pieri, L.
    Compounds for using in imagery and particularly for the diagnosis of neuro​degenerative diseases
    4. Patent N° Kind Date Application N° Date
    WO 2018055316 A1 29 mar. 2018 WO 2017-FR52592 26 sep. 2017
    FR 3056592 A1 30 mar. 2018 FR 2016-59033 26 sep. 2016
    FR 3056592 B1 16 nov. 2018
    EP 3515912 A1 31 Jul. 2019 EP 2017-783941 26 Sep. 2017
    EP 3515912 B1 14 Oct. 2020
    US 20190211011 A1 11 Jul. 2019 US 2019-1633630925 Mar. 2019

        Priority :
                      FR 2016-59033 A 26 sep. 2016
                      FR 2017-52001 A 10 mar. 2017
                      WO 2017-FR52592 W 26 Sep. 2017
        ref. chem. Abstract : 168:387407

  4. Routier, S. ; Bénédetti, H. ; Buron, F. ; Hiebel, M.-A. ; Saurat, T. ; Guillaumet, G.
    Preparation of trisubstituted pyrido[2,​3-​d]​pyrimidines as inhibitors of PI3K and mTOR kinases
    5. Patent N° Kind Date Application N° Date
    FR 2994572 A1 21 Feb 2014 FR 2012-57856 17 Aug 2012
    FR 2994572 B1 17 Apr 2015
    CA 2881110 A1 20 Feb 2014 CA 2013-2881110 16 Aug 2013
    WO 2014027081 A1 20 Feb 2014 WO 2013-EP67129 16 Aug 2013
    AU 2013304046 A1 26 Feb 2015 AU 2013-304046 16 Aug 2013
    KR 2015046155 A 29 Apr 2015 KR 2015-7006805 16 Aug 2013
    CN 104718203 A 17Jun 2015 CN 2013-80049835 16 Aug 2013
    EP 2885297 A1 24 Jun 2015 EP 2013-750072 16 Aug 2013
    EP 2885297 B1 11 oct. 2017
    BR 112015003033 A2 8 Aug. 2017 BR 2015-112015003033 16 Aug 2013
    ES 2655284 T3 19 Feb. 2018 ES 2013-750072 16 Aug. 2013
    US 20150203489 A1 23 Jul 2015 US 2015-14421402 12 Feb 2015
    US 10202372 B2 12 Feb. 2019
    AU 2017272233 A1 4 Jan. 2018 AU 2017-272233 6 Dec.2017

        Priority application :
                      FR 2012-57856 A 17 Aug. 2012
                      WO 2013-EP67129 W 16 Aug. 2013
                      AU 2013-304046 A3 16 Aug. 2013
        ref. chem. Abstract : 160:370183

  5. Routier, S. ; Suzenet, F. ; Pin, F. ; Chalon, S. ; Vercouillie, J. ; Guilloteau, D.
    Preparation of 1,4-disubstituted 1,2,3-triazoles, especially triazolyltropanes and triazolylquinuclidines, as α7 nicotinic receptor modulators useful as diagnostic and thera
    6. Patent N° Kind Date Application N° Date
    FR 2974365 A1 26 oct. 2012 FR 2011-53420 20 apr. 2011
    FR 2974365 B1 25 Aug. 2017
    CA 2833648 A1 26 oct. 2012 CA 2012-2833648 20 apr. 2012
    CA 2833648 C 4 Aug. 2020
    WO 2012143526 A1 26 oct. 2012 WO 2012-EP57309 20 apr. 2012
    AU 2012245118 A1 7 nov. 2013 AU 2012-245118 20 apr. 2012
    EP 2699570 A1 26 feb. 2014 EP 2012-715117 20 apr. 2012
    EP 2699570 B1 22 Aug. 2018
    CN 103649084 A 19 mar. 2014 CN 2012-80029991 20 apr. 2012
    CN 103649084 B 29 Mar. 2017
    JP 2014515754 T 3 jul. 2014 JP 2014-505656 20 apr. 2012
    JP 5969004 B2 10 Aug. 2016
    US 20140030191 A1 30 jan. 2014 US 2013-14112864 18 oct. 2013
    US 10059704 B2 28 Aug. 2018

        Priority :
                      FR 2011-53420 A, 20 Apr 2011
                      WO 2012-EP57309 W, 20 Apr 2012
        ref. chem. Abstract : 157:663263

  6. Routier, S. ; Guillaumet, G. ; Tikad, A. ; Dehbi, O.
    Preparation of pyrido[3,2-d]pyrimidine derivatives as inhibitors of CDK1, DYRK1A, CDK5 and/or GSK3 kinases
    7. Patent N° Kind Date Application N° Date
    FR 2959510 A1 03 nov. 2011 FR 2010-53277 28 apr. 2010
    FR 2959510 B1 26 apr. 2013
    WO 2011135259 A1 3 nov. 2011 WO 2011-FR50959 28 apr. 2011
    US 20130109693 A1 2 may. 2013 US 2012-695001 20 dec. 2012

        Priority application :
                      FR2010-53277 A 28 apr. 2010
                      WO 2011-FR50959 W 28 apr. 2011
        ref. chem. Abstract : 155:637809